Identification of an NFIA::CBFA2T3 fusion in cerebrospinal fluid confirms the diagnosis of pediatric CNS myeloid sarcoma with erythroid differentiation: a case report and literature review - Top-Institutions - MDSpire

Identification of an NFIA::CBFA2T3 fusion in cerebrospinal fluid confirms the diagnosis of pediatric CNS myeloid sarcoma with erythroid differentiation: a case report and literature review

  • By

  • Yang Zhao

  • Zhizhuo Huang

  • Lian Xue

  • Leping Zhang

  • Yueping Jia

  • May 12, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Cincinnati Children's Hospital Medical Center
    Cincinnati Children's Hospital Medical Center

    Cincinnati, Ohio

    Key Differentiators

    • Pediatric Oncology
    • Hematology

  • #2

    Children's Hospital of Philadelphia
    Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania

    Key Differentiators

    • Pediatric Oncology
    • Hematology

  • #3

    National Cancer Institute
    National Cancer Institute

    Bethesda, Maryland

    Key Differentiators

    • Oncology
    • Hematology

Original Source(s)

Identification of an NFIA::CBFA2T3 fusion in cerebrospinal fluid confirms the diagnosis of pediatric CNS myeloid sarcoma with erythroid differentiation: a case report and literature review

  • by Yang Zhao, Zhizhuo Huang, Lian Xue, Leping Zhang, Yueping Jia

  • May 12, 2026

Related Content

Retraction: MicroRNA-935 directly targets FZD6 to inhibit the proliferation of human glioblastoma and correlate to glioma malignancy and prognosis

  • May 28, 2026

Trametinib as second-line therapy for advanced KRAS G12C-mutant non-small cell lung cancer: a single-center clinical analysis of 20 cases

Impact of the clonal architecture and probable biallelic inactivation of TET2 mutations in myelodysplastic neoplasms